CES event showcased cutting-edge health tech innovations, including smart diapers, AI-powered glasses, and a walking ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal exc ...

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

In a new case study, researchers from North Carolina State University found that a family suffering from illnesses that included neurological symptoms were co-infected with both several Bartonella ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

With the introduction of 200 daycare cancer centers, advanced diagnostics, improved access to treatment, and a ...

Not a day goes by without another news story, device, treatment, supplement, podcast, research paper, statistic – you get the ...

The approval was based on a Phase 3 study showing significant reductions in daily OFF time and increases in GOOD ON time. Supernus CEO Jack Khattar expressed the company's commitment to developing ...